R
Ross D. Jones
Researcher at Massachusetts Institute of Technology
Publications - 18
Citations - 205
Ross D. Jones is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Synthetic biology & Medicine. The author has an hindex of 6, co-authored 13 publications receiving 102 citations. Previous affiliations of Ross D. Jones include University of Washington & University of British Columbia.
Papers
More filters
Journal ArticleDOI
An endoribonuclease-based feedforward controller for decoupling resource-limited genetic modules in mammalian cells.
Ross D. Jones,Yili Qian,Velia Siciliano,Breanna DiAndreth,Jin Huh,Ron Weiss,Domitilla Del Vecchio +6 more
TL;DR: An endoribonuclease-based feedforward controller is developed that can adapt the expression level of a gene of interest to significant resource loading in mammalian cells and is a general-purpose device for predictable, robust, and context-independent control of gene expression.
Journal ArticleDOI
A 'poly-transfection' method for rapid, one-pot characterization and optimization of genetic systems.
TL;DR: One-pot evaluation enabled by poly-transfection accelerates and simplifies the design of genetic systems, providing a new high-information strategy for interrogating biology.
Journal ArticleDOI
miRNA sensitivity to Drosha levels correlates with pre-miRNA secondary structure.
Henrik Sperber,Alan Beem,Sandra Shannon,Ross D. Jones,Pratyusha Banik,Yu Chen,Sherman Ku,Gabriele Varani,Shuyuan Yao,Hannele Ruohola-Baker +9 more
TL;DR: Statistical analysis of miRNA secondary structure and fold change of expression in response to Drosha knockdown showed that absence of mismatches in the central region of the hairpin, 5 and 9-12 nt from the Drosha cutting site conferred decreased sensitivity to Dro Sha knockdown, suggesting that, when limiting, Drosha processes miRNAs without mismatches more efficiently than mismatched mi RNAs.
Journal ArticleDOI
Context-aware synthetic biology by controller design: Engineering the mammalian cell.
TL;DR: In this article, the authors describe control systems approaches for achieving context-aware devices that are robust to context effects, and then consider cell fate programing as a case study to explore the potential impact of contextaware devices for regenerative medicine applications.
Journal Article
Effects of Antioxidants and Pro-oxidants on Cytotoxicity of Dihydroartemisinin to Molt-4 Human Leukemia Cells
Thomas E. Gerhardt,Ross D. Jones,Jungsoo Park,Rui Lu,Ho Wing Chan,Qingxi Fang,Narendra P. Singh,Henry Lai +7 more
TL;DR: Cellular oxidative status could alter the potency of artemisinin in killing cancer cells, and antioxidants would reduce, whereas pro-oxidants would enhance, cytotoxicity.